Dose-dependent efficacy of miglitol, an alpha-glucosidase inhibitor, in type 2 diabetic patients on diet alone: results of a 24-week double-blind placebo-controlled study

Autor: Drent, M L, Tollefsen, A T M, van Heusden, F H J A, Hoenderdos, E B M, Jonker, J J C, van der Veen, E A

Publikováno v: Diabetes, nutrition & metabolism, 15(3), 152-9. Editrice Kurtis s.r.l.

AIMS: A double-blind randomised study was performed to compare the dose-effect and dose-tolerability relationships between the alpha-glucosidase inhibitor miglitol in doses of 25 mg, 50 mg, 100 mg and 200 mg all t.i.d. vs placebo t.i.d. in patients w

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::0ab81e07647e880fd7004b66ed3cb564
https://research.vumc.nl/en/publications/eeb7c94f-3a8f-4b2b-a315-e04a935c5bff

Dose-dependent efficacy of miglitol, an alfa-glucosidase inhibitor, in type 2 diabetic patients: results of a 24-week double-blind placebo-controlled study

Autor: Drent, M.L., Tollefsen, A.T.M., van Heusden, F.H.J.A., Hoenderdos, E.B.M., Jonker, J.J.C., van der Veen, E.A.

Publikováno v: Diabetes, Nutrition and Metabolism, Clinical and Experimental, 15, 152-159. Editrice Kurtis s.r.l.
Drent, M L, Tollefsen, A T M, van Heusden, F H J A, Hoenderdos, E B M, Jonker, J J C & van der Veen, E A 2002, ' Dose-dependent efficacy of miglitol, an alfa-glucosidase inhibitor, in type 2 diabetic patients: results of a 24-week double-blind placebo-controlled study. ', Diabetes, Nutrition and Metabolism, Clinical and Experimental, vol. 15, pp. 152-159 .

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::1750103d86d5ba068e6c877324096dee
https://hdl.handle.net/1871.1/5c93057f-9f41-4630-9176-7e71448c9f7c